Outlook Quality of Life Intervention

Sponsor
VA Office of Research and Development (U.S. Fed)
Overall Status
Completed
CT.gov ID
NCT00784095
Collaborator
(none)
36
1
3
5
7.3

Study Details

Study Description

Brief Summary

The purpose of this study is to determine whether discussions of life story, forgiveness, and future goals improve quality of life for patients with serious illness.

Condition or Disease Intervention/Treatment Phase
  • Other: Life completion and preparation
  • Other: Attention Control
N/A

Detailed Description

This is a pilot randomized control trial to evaluate the feasibility of the Outlook intervention. 36 veterans with advanced cancer, congestive heart failure (CHF) or chronic obstructive pulmonary disease (COPD) will be randomly assigned to one of three intervention groups and complete a brief battery of pre-test measures. Subjects in the first group ("treatment") will meet with a facilitator three times for a period of 45 min-1 hour. In the first session, subjects will be asked to discuss issues related to life review. In the second session, participants will be asked to speak in more depth about issues such as regret, forgiveness and things left undone, In the final session, subjects will focus on heritage and legacy. The subjects in the second group ("attention control") will meet with a facilitator three times for a period of 45 min- 1 hour and listen to a non-guided relaxation compact disk (CD). The third group of participants ("true control") will be exposed to no intervention or attention control. One week and two weeks later, participants in all groups will receive post-test measures administered by a blinded interviewer.

Study Design

Study Type:
Interventional
Actual Enrollment :
36 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Official Title:
Outlook: An Intervention to Improve Quality of Life in Serious Illness
Study Start Date :
Dec 1, 2008
Actual Primary Completion Date :
May 1, 2009
Actual Study Completion Date :
May 1, 2009

Arms and Interventions

Arm Intervention/Treatment
Experimental: Preparation and Completion

Subjects in the first group ("treatment") met with the facilitator three times for a period of forty-five minutes to one hour to discuss issues of life completion and preparation. In the first session, subjects were asked to discuss issues related to life review. In session two, participants spoke about issues of regret and forgiveness. In the final session, subjects discussed issues of heritage and legacy.

Other: Life completion and preparation
Subjects will discuss life review, issues of forgiveness and heritage and legacy.

Active Comparator: Attention Control

The subjects in the second group ("attention control") met with a facilitator three times for 45 minutes and listened to a non-guided relaxation CD.

Other: Attention Control
Subjects will listen to a non-guided relaxation CD.

No Intervention: True Control

Subjects in the third group ("true control") were exposed to no intervention or attention control.

Outcome Measures

Primary Outcome Measures

  1. Quality of Life - Preparation [Baseline, 6 and 8 week follow up]

    Quality Of Life At The End Of Life (the QUAL-E 2009) is a 31 item measure of quality of life at the end of life assessing five domains: life completion, relationship with health care providers, preparation for death, physical symptoms and affective social support. The 4-item preparation sub-scale is a primary outcomes measure with each item scaled from 1 to 5 with a minimum of 5, maximum of 20 score with higher scores indicating better preparation.

  2. QUAL-E Completion Sub-scale [Baseline, 6 and 8 week follow up]

    A sub-scale of the QUAL-E quality of life at the end of life measures. The scale range was 5-35 with higher scores indicating more positive sense of completion.

Secondary Outcome Measures

  1. Functional Status ADL [Baseline, 6 and 8 week follow ups]

    Rosow-Breslau Activities of Daily Living scale range 17-51 with higher scores indicating greater ability.

  2. Center for Epidemiology Studies - Depression Scale (CES-D) [Baseline, 6 and 8 week follow up]

    Center for Epidemiology Studies - Depression Scale (CES-D) is a 10-item measure of depression. Items are rated on a 4 point likert scale with total scores ranging from 0-30. Higher scores indicate greater depressive symptoms.

  3. POMS Anxiety Sub-scale [Baseline, 6 and 8 week follow ups]

    The anxiety sub-scale from the modified Brief Profile of Mood States (POMS) is a 5-item measure of psychological distress.Items are on a 5-point likert scale with scoring ranging from 5-25. Higher scores indicate greater anxiety.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:

Patients with advanced cancer, CHF or COPD.

Exclusion Criteria:

Cognitive impairment, inability to speak, non-English speaking

Contacts and Locations

Locations

Site City State Country Postal Code
1 Durham VA Medical Center HSR&D COE Durham North Carolina United States 27705

Sponsors and Collaborators

  • VA Office of Research and Development

Investigators

  • Principal Investigator: Karen E. Steinhauser, PhD, Durham VA Medical Center HSR&D COE

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
VA Office of Research and Development
ClinicalTrials.gov Identifier:
NCT00784095
Other Study ID Numbers:
  • IAD 07-162
First Posted:
Nov 2, 2008
Last Update Posted:
Mar 22, 2016
Last Verified:
Mar 1, 2016
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Keywords provided by VA Office of Research and Development
Additional relevant MeSH terms:

Study Results

Participant Flow

Recruitment Details
Pre-assignment Detail
Arm/Group Title Preparation and Completion Attention Control True Control
Arm/Group Description Subjects in the first group ("treatment")will meet with the facilitator three times for a period of forty-five minutes to one our. In the first session, subjects will be asked to discuss issues related to life review. In session two, participants will speak about issues of regret and forgiveness. In the final session, subjects will focus on heritage and legacy. Life completion and preparation: Subjects will discuss life review, issues of forgiveness and heritage and legacy. The subjects in the second group ("attention control") will meet with a facilitator three times for 45 minutes and listen to a non-guided relaxation CD. Attention Control: Subjects will listen to a non-guided relaxation CD. Subjects in the third group ("true control") will be exposed to no intervention or attention control.
Period Title: Overall Study
STARTED 12 12 12
COMPLETED 12 11 11
NOT COMPLETED 0 1 1

Baseline Characteristics

Arm/Group Title Preparation and Completion Attention Control True Control Total
Arm/Group Description Subjects in the first group ("treatment")will meet with the facilitator three times for a period of forty-five minutes to one our. In the first session, subjects will be asked to discuss issues related to life review. In session two, participants will speak about issues of regret and forgiveness. In the final session, subjects will focus on heritage and legacy. Life completion and preparation: Subjects will discuss life review, issues of forgiveness and heritage and legacy. The subjects in the second group ("attention control") will meet with a facilitator three times for 45 minutes and listen to a non-guided relaxation CD. Attention Control: Subjects will listen to a non-guided relaxation CD. Subjects in the third group ("true control") will be exposed to no intervention or attention control. Total of all reporting groups
Overall Participants 12 12 12 36
Age (years) [Mean (Standard Deviation) ]
Mean (Standard Deviation) [years]
64
(10)
68
(10)
69
(14)
67
(11)
Sex: Female, Male (Count of Participants)
Female
0
0%
1
8.3%
0
0%
1
2.8%
Male
12
100%
11
91.7%
12
100%
35
97.2%
Race (NIH/OMB) (Count of Participants)
American Indian or Alaska Native
0
0%
0
0%
0
0%
0
0%
Asian
0
0%
0
0%
0
0%
0
0%
Native Hawaiian or Other Pacific Islander
0
0%
0
0%
0
0%
0
0%
Black or African American
5
41.7%
5
41.7%
4
33.3%
14
38.9%
White
7
58.3%
5
41.7%
5
41.7%
17
47.2%
More than one race
0
0%
0
0%
0
0%
0
0%
Unknown or Not Reported
0
0%
2
16.7%
3
25%
5
13.9%
Region of Enrollment (participants) [Number]
United States
12
100%
12
100%
12
100%
36
100%

Outcome Measures

1. Primary Outcome
Title Quality of Life - Preparation
Description Quality Of Life At The End Of Life (the QUAL-E 2009) is a 31 item measure of quality of life at the end of life assessing five domains: life completion, relationship with health care providers, preparation for death, physical symptoms and affective social support. The 4-item preparation sub-scale is a primary outcomes measure with each item scaled from 1 to 5 with a minimum of 5, maximum of 20 score with higher scores indicating better preparation.
Time Frame Baseline, 6 and 8 week follow up

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title Preparation and Completion Attention Control True Control
Arm/Group Description Subjects in the first group ("treatment")will meet with the facilitator three times for a period of forty-five minutes to one our. In the first session, subjects will be asked to discuss issues related to life review. In session two, participants will speak about issues of regret and forgiveness. In the final session, subjects will focus on heritage and legacy. Life completion and preparation: Subjects will discuss life review, issues of forgiveness and heritage and legacy. The subjects in the second group ("attention control") will meet with a facilitator three times for 45 minutes and listen to a non-guided relaxation CD. Attention Control: Subjects will listen to a non-guided relaxation CD. Subjects in the third group ("true control") will be exposed to no intervention or attention control.
Measure Participants 12 11 11
Baseline
14.4
(3.9)
16.0
(3.7)
15.4
(4.4)
6 week follow up
15.2
(3.8)
14.8
(5.1)
14.5
(3.9)
8 week follow up
16.3
(2.7)
16.1
(4.6)
14.5
(4.4)
Statistical Analysis 1
Statistical Analysis Overview Comparison Group Selection Preparation and Completion, True Control
Comments Intervention (Preparation and Completion) versus True Control at 8 weeks
Type of Statistical Test Superiority or Other
Comments
Statistical Test of Hypothesis p-Value .047
Comments
Method Mixed Models Analysis
Comments
Method of Estimation Estimation Parameter Mean Difference (Final Values)
Estimated Value 2.9
Confidence Interval (2-Sided) 95%
.04 to 5.7
Parameter Dispersion Type:
Value:
Estimation Comments
Statistical Analysis 2
Statistical Analysis Overview Comparison Group Selection Preparation and Completion, Attention Control
Comments Intervention (Preparation and Completion) versus Attention Control at 8 weeks
Type of Statistical Test Superiority or Other
Comments
Statistical Test of Hypothesis p-Value
Comments
Method
Comments
Method of Estimation Estimation Parameter Mean Difference (Final Values)
Estimated Value 1.8
Confidence Interval (2-Sided) 95%
-1.1 to 4.7
Parameter Dispersion Type:
Value:
Estimation Comments
2. Secondary Outcome
Title Functional Status ADL
Description Rosow-Breslau Activities of Daily Living scale range 17-51 with higher scores indicating greater ability.
Time Frame Baseline, 6 and 8 week follow ups

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title Preparation and Completion Attention Control True Control
Arm/Group Description Subjects in the first group ("treatment")met with the facilitator three times for a period of forty-five minutes to one hour to discuss issues of life completion and preparation. In the first session, subjects were asked to discuss issues related to life review. In session two, participants spoke about issues of regret and forgiveness. In the final session, subjects discussed issues of heritage and legacy. Life completion and preparation: Subjects will discuss life review, issues of forgiveness and heritage and legacy. The subjects in the second group ("attention control") met with a facilitator three times for 45 minutes and listened to a non-guided relaxation CD. Attention Control: Subjects will listen to a non-guided relaxation CD. Subjects in the third group ("true control") were exposed to no intervention or attention control.
Measure Participants 12 11 11
Baseline
22.3
(4.4)
21.0
(2.3)
29.7
(6.4)
6 week follow up
23
(5.7)
24
(8.1)
30.6
(8.2)
8 week follow up
23.1
(5.3)
21.8
(4.0)
29.8
(8.0)
Statistical Analysis 1
Statistical Analysis Overview Comparison Group Selection Preparation and Completion, True Control
Comments Intervention (Preparation and Completion) versus True Control at 8 weeks
Type of Statistical Test Superiority or Other
Comments
Statistical Test of Hypothesis p-Value
Comments
Method
Comments
Method of Estimation Estimation Parameter Mean Difference (Final Values)
Estimated Value 1.2
Confidence Interval (2-Sided) 95%
-3.2 to 5.6
Parameter Dispersion Type:
Value:
Estimation Comments
Statistical Analysis 2
Statistical Analysis Overview Comparison Group Selection Preparation and Completion, Attention Control
Comments Intervention (Preparation and Completion) versus Attention Control at 8 weeks
Type of Statistical Test Superiority or Other
Comments
Statistical Test of Hypothesis p-Value
Comments
Method
Comments
Method of Estimation Estimation Parameter Mean Difference (Final Values)
Estimated Value -1.1
Confidence Interval (2-Sided) 95%
-5.6 to 3.3
Parameter Dispersion Type:
Value:
Estimation Comments
3. Secondary Outcome
Title Center for Epidemiology Studies - Depression Scale (CES-D)
Description Center for Epidemiology Studies - Depression Scale (CES-D) is a 10-item measure of depression. Items are rated on a 4 point likert scale with total scores ranging from 0-30. Higher scores indicate greater depressive symptoms.
Time Frame Baseline, 6 and 8 week follow up

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title Preparation and Completion Attention Control True Control
Arm/Group Description Subjects in the first group ("treatment")met with the facilitator three times for a period of forty-five minutes to one hour to discuss issues of life completion and preparation. In the first session, subjects were asked to discuss issues related to life review. In session two, participants spoke about issues of regret and forgiveness. In the final session, subjects discussed issues of heritage and legacy. Life completion and preparation: Subjects will discuss life review, issues of forgiveness and heritage and legacy. The subjects in the second group ("attention control") met with a facilitator three times for 45 minutes and listened to a non-guided relaxation CD. Attention Control: Subjects will listen to a non-guided relaxation CD. Subjects in the third group ("true control") were exposed to no intervention or attention control.
Measure Participants 12 11 11
Baseline
12.0
(5.0)
12.0
(8.3)
13.4
(6.6)
6 week follow up
12.4
(5.4)
12.6
(7.7)
12.3
(6.8)
8 week follow up
9.4
(4.2)
12.5
(8.9)
12.1
(5.9)
Statistical Analysis 1
Statistical Analysis Overview Comparison Group Selection Preparation and Completion, True Control
Comments Intervention (Preparation and Completion) versus True Control at 8 weeks
Type of Statistical Test Superiority or Other
Comments
Statistical Test of Hypothesis p-Value
Comments
Method
Comments
Method of Estimation Estimation Parameter Mean Difference (Final Values)
Estimated Value -1.6
Confidence Interval (2-Sided) 95%
-6.2 to 2.9
Parameter Dispersion Type:
Value:
Estimation Comments
Statistical Analysis 2
Statistical Analysis Overview Comparison Group Selection Preparation and Completion, Attention Control
Comments Intervention (Preparation and Completion) versus Attention Control at 8 weeks
Type of Statistical Test Superiority or Other
Comments
Statistical Test of Hypothesis p-Value
Comments
Method
Comments
Method of Estimation Estimation Parameter Mean Difference (Final Values)
Estimated Value -3.6
Confidence Interval (2-Sided) 95%
-8.2 to 1.0
Parameter Dispersion Type:
Value:
Estimation Comments
4. Secondary Outcome
Title POMS Anxiety Sub-scale
Description The anxiety sub-scale from the modified Brief Profile of Mood States (POMS) is a 5-item measure of psychological distress.Items are on a 5-point likert scale with scoring ranging from 5-25. Higher scores indicate greater anxiety.
Time Frame Baseline, 6 and 8 week follow ups

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title Preparation and Completion Attention Control True Control
Arm/Group Description Subjects in the first group ("treatment")met with the facilitator three times for a period of forty-five minutes to one hour to discuss issues of life completion and preparation. In the first session, subjects were asked to discuss issues related to life review. In session two, participants spoke about issues of regret and forgiveness. In the final session, subjects discussed issues of heritage and legacy. Life completion and preparation: Subjects will discuss life review, issues of forgiveness and heritage and legacy. The subjects in the second group ("attention control") met with a facilitator three times for 45 minutes and listened to a non-guided relaxation CD. Attention Control: Subjects will listen to a non-guided relaxation CD. Subjects in the third group ("true control") were exposed to no intervention or attention control.
Measure Participants 12 11 11
Baseline
5.0
(5.5)
4.1
(4.1)
5.3
(4.4)
6 week follow up
5.1
(4.9)
5.0
(4.0)
5.9
(4.4)
8 week follow up
4.6
(3.3)
4.8
(5.4)
5.3
(4.2)
Statistical Analysis 1
Statistical Analysis Overview Comparison Group Selection Preparation and Completion, True Control
Comments Intervention (Preparation and Completion) versus True Control at 8 weeks
Type of Statistical Test Superiority or Other
Comments
Statistical Test of Hypothesis p-Value
Comments
Method
Comments
Method of Estimation Estimation Parameter Mean Difference (Final Values)
Estimated Value -0.6
Confidence Interval (2-Sided) 95%
-4.5 to 3.4
Parameter Dispersion Type:
Value:
Estimation Comments
Statistical Analysis 2
Statistical Analysis Overview Comparison Group Selection Preparation and Completion, Attention Control
Comments Intervention versus Attention Control at 8 weeks.
Type of Statistical Test Superiority or Other
Comments
Statistical Test of Hypothesis p-Value
Comments
Method
Comments
Method of Estimation Estimation Parameter Mean Difference (Final Values)
Estimated Value -1.1
Confidence Interval (2-Sided) 95%
-5.1 to 3.0
Parameter Dispersion Type:
Value:
Estimation Comments
5. Primary Outcome
Title QUAL-E Completion Sub-scale
Description A sub-scale of the QUAL-E quality of life at the end of life measures. The scale range was 5-35 with higher scores indicating more positive sense of completion.
Time Frame Baseline, 6 and 8 week follow up

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title Preparation and Completion Attention Control True Control
Arm/Group Description Subjects in the first group ("treatment")met with the facilitator three times for a period of forty-five minutes to one hour to discuss issues of life completion and preparation. In the first session, subjects were asked to discuss issues related to life review. In session two, participants spoke about issues of regret and forgiveness. In the final session, subjects discussed issues of heritage and legacy. Life completion and preparation: Subjects will discuss life review, issues of forgiveness and heritage and legacy. The subjects in the second group ("attention control") met with a facilitator three times for 45 minutes and listened to a non-guided relaxation CD. Attention Control: Subjects will listen to a non-guided relaxation CD. Subjects in the third group ("true control") were exposed to no intervention or attention control.
Measure Participants 12 11 11
Baseline
22.4
(6.5)
24.5
(5.2)
22.5
(6.9)
6 week follow up
22.6
(5.6)
25.3
(5.2)
23.1
(6.1)
8 week follow up
23.4
(5.6)
24.1
(5.9)
24.4
(7.7)
Statistical Analysis 1
Statistical Analysis Overview Comparison Group Selection Preparation and Completion, True Control
Comments Intervention (Preparation and Completion) versus True Control at 8 weeks
Type of Statistical Test Superiority or Other
Comments
Statistical Test of Hypothesis p-Value
Comments
Method
Comments
Method of Estimation Estimation Parameter Mean Difference (Final Values)
Estimated Value -.6
Confidence Interval (2-Sided) 95%
-4.8 to 3.7
Parameter Dispersion Type:
Value:
Estimation Comments
Statistical Analysis 2
Statistical Analysis Overview Comparison Group Selection Preparation and Completion, Attention Control
Comments Intervention (Preparation and Completion) versus Attention Control at 8 weeks.
Type of Statistical Test Superiority or Other
Comments
Statistical Test of Hypothesis p-Value
Comments
Method
Comments
Method of Estimation Estimation Parameter Mean Difference (Final Values)
Estimated Value 2.4
Confidence Interval (2-Sided) 95%
-1.9 to 6.7
Parameter Dispersion Type:
Value:
Estimation Comments

Adverse Events

Time Frame
Adverse Event Reporting Description
Arm/Group Title Preparation and Completion Attention Control True Control
Arm/Group Description Subjects in the first group ("treatment") met with the facilitator three times for a period of forty-five minutes to one our. In the first session, subjects were asked to discuss issues related to life review. In session two, participants spoke about issues of regret and forgiveness. In the final session, subjects focused on heritage and legacy. Life completion and preparation: Subjects will discuss life review, issues of forgiveness and heritage and legacy. The subjects in the second group ("attention control") met with a facilitator three times for 45 minutes and listen to a non-guided relaxation CD. Attention Control: Subjects listened to a non-guided relaxation CD. Subjects in the third group ("true control") were exposed to no intervention or attention control.
All Cause Mortality
Preparation and Completion Attention Control True Control
Affected / at Risk (%) # Events Affected / at Risk (%) # Events Affected / at Risk (%) # Events
Total / (NaN) / (NaN) / (NaN)
Serious Adverse Events
Preparation and Completion Attention Control True Control
Affected / at Risk (%) # Events Affected / at Risk (%) # Events Affected / at Risk (%) # Events
Total 0/12 (0%) 1/12 (8.3%) 0/12 (0%)
General disorders
Death 0/12 (0%) 0 1/12 (8.3%) 1 0/12 (0%) 0
Other (Not Including Serious) Adverse Events
Preparation and Completion Attention Control True Control
Affected / at Risk (%) # Events Affected / at Risk (%) # Events Affected / at Risk (%) # Events
Total 0/12 (0%) 0/12 (0%) 0/12 (0%)

Limitations/Caveats

Therefore, due to the small sample size, finding are met with caution. Subjects were not randomized by any condition. As a result, those in the Control arm were more functionally able than the other two arms at baseline.

More Information

Certain Agreements

All Principal Investigators ARE employed by the organization sponsoring the study.

There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.

Results Point of Contact

Name/Title Dr. Karen Steinhauser
Organization VA Health Services Research and Development
Phone 9196682148
Email karen.steinhauser@va.gov
Responsible Party:
VA Office of Research and Development
ClinicalTrials.gov Identifier:
NCT00784095
Other Study ID Numbers:
  • IAD 07-162
First Posted:
Nov 2, 2008
Last Update Posted:
Mar 22, 2016
Last Verified:
Mar 1, 2016